Gripum claims the MDO was unfairly issued because Congress and FDA had no “ascertainable standards."Read More
Tags :PMTA
Vapor Makers Prevail Over FDA in PMTA Denial Suit
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
Despite onerous requirements on applicants, the agency was happy to cut its own paperwork, writes Filter.Read More
CTP's King stated that the agency was "making significant progress" in reviewing the applications.Read More
Altria reduced the value of its investment in Juul Labs nearly 70 percent of its original $12.8 billion.Read More
The laboratory provides all non-clinical evidence required to bring a new nicotine product to market.Read More
The limited product debut in the UK has received overwhelming recognition from users and commercial partners.Read More
The announcement comes as FDA Commissioner Robert Califf attempts to push past several controversies.Read More
A spokesperson for Juul Labs told Reuters that the company is looking at options to protect its business.Read More
One store owner said the majority of customers who buy Juuls aren’t using them to stop smoking.Read More